Journal article · 1997
Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis
Current Opinion in Rheumatology, 9(6), 571–575 · Published 1 November 1997 · DOI 10.1097/00002281-199711000-00014
In brief
“Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis” is a 1997 journal article by James R. Seibold and Deborah McCloskey, published in Current Opinion in Rheumatology. OpenAlex counts 23 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 23
- Most cited in
- 2021 (2)
- Field-weighted impact
- 0.25
- Authors
- 2
Abstract
Advances in our understanding of the pathobiology of scleroderma and the ever-increasing availability of rational candidate therapies have brought the clinical study of scleroderma to the forefront. In the 1990s, consensus measures of outcome have been developed for common disorders such as rheumatoid arthritis. With decisions founded on extensive and validated data, the clinical research… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Seibold, J. R., & McCloskey, D. (1997). Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis. Current Opinion in Rheumatology, 9(6), 571–575. https://doi.org/10.1097/00002281-199711000-00014
MLA 9
Seibold, James R., and Deborah McCloskey. “Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis.” Current Opinion in Rheumatology, vol. 9, no. 6, 1997, pp. 571–575. https://doi.org/10.1097/00002281-199711000-00014.
Chicago
Seibold, James R. and Deborah McCloskey. 1997. “Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis.” Current Opinion in Rheumatology 9 (6): 571–575. https://doi.org/10.1097/00002281-199711000-00014.
Harvard
Seibold, J. R. and McCloskey, D. (1997) ‘Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis’, Current Opinion in Rheumatology, 9(6), pp. 571–575. doi:10.1097/00002281-199711000-00014.
IEEE
J. R. Seibold and D. McCloskey, “Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis,” Current Opinion in Rheumatology, vol. 9, no. 6, pp. 571–575, 1997, doi: 10.1097/00002281-199711000-00014.
BibTeX
@article{seibold1997skin,
title = {{Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis}},
author = {Seibold, James R. and McCloskey, Deborah},
journal = {Current Opinion in Rheumatology},
year = {1997},
volume = {9},
number = {6},
pages = {571--575},
doi = {10.1097/00002281-199711000-00014},
url = {https://doi.org/10.1097/00002281-199711000-00014}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2012 | 1 | |
| 2014 | 1 | |
| 2018 | 1 | |
| 2021 | 2 |
Its field-weighted citation impact is 0.25: it has been cited 0.25 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- systemic sclerosis
- skin involvement
- outcome measures
- clinical trial endpoints
- disease activity assessment
- quality of life
- drug development
- rheumatoid arthritis comparison
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Seibold, J. R., & McCloskey, D. (1997). Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis. Current Opinion in Rheumatology, 9(6), 571–575. https://doi.org/10.1097/00002281-199711000-00014
How many times has this paper been cited?
23 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
James R. Seibold, Deborah McCloskey.
What is the DOI of this paper?
10.1097/00002281-199711000-00014, permanently at https://doi.org/10.1097/00002281-199711000-00014. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.